NCT00327054View on ClinicalTrials.gov

Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

March 31, 2007

Conditions
HypercholesterolemiaHypertensionDiabetes MellitusMetabolic Syndrome X
Interventions
DRUG

Nigella sativa seed

Trial Locations (1)

74800

Aga Khan University, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER

NCT00327054 - Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia | Biotech Hunter | Biotech Hunter